$AKTX Akari Therapeutics Plc Insider Trading
Get free email notifications about insider trading in Akari Therapeutics Plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Akari Therapeutics Plc. Insider overview, share value development, latest insider transactions and email notifications about new events in Akari Therapeutics Plc for free.
CIK Number: 0001541157
IRS Number: 981034922
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AKTX
Company Address: 24 WEST 40TH STREET 8TH FLOOR NEW YORK 10018
Phone number: +44 20 8004 0270
Former name: Morria Biopharmaceuticals PLC, date of change: 2012-02-01
Former name: Celsus Therapeutics Plc., date of change: 2013-06-21
Market Capitalization: $82.90M
Prev close: $7.00
Average Daily Volume: 2,231
Days Low: $7.00
Year Low: $6.71
Year High: $19.75
Akari Therapeutics Plc Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 30 2016 | AKTX | Akari Therapeutics ... | Cohen Mark S | Director | Option Exercise | A | 0.15 | 1,300,000 | 189,020 | 1,300,000 | |
Jun 30 2016 | AKTX | Akari Therapeutics ... | Byrne David | Director | Option Exercise | A | 0.15 | 1,300,000 | 189,020 | 1,300,000 | |
Jun 30 2016 | AKTX | Akari Therapeutics ... | Hill James | Director | Option Exercise | A | 0.15 | 1,300,000 | 189,020 | 1,300,000 | |
Jun 30 2016 | AKTX | Akari Therapeutics ... | Ungar Stuart | Director | Option Exercise | A | 0.15 | 1,300,000 | 189,020 | 1,300,000 | |
Jun 30 2016 | AKTX | Akari Therapeutics ... | Williams Donald Allen | Director | Option Exercise | A | 0.15 | 1,300,000 | 189,020 | 1,300,000 | |
Jun 30 2016 | AKTX | Akari Therapeutics ... | Williams Donald Allen | Director | Option Exercise | A | 0.15 | 1,300,000 | 189,020 | 1,300,000 | |
Apr 26 2016 | AKTX | Akari Therapeutics ... | Byrne David | Director | Option Exercise | A | 17.96 | 1,300,000 | 23,348,000 | 1,300,000 | |
Mar 25 2016 | AKTX | Akari Therapeutics ... | SHAW ROBERT M | General Counsel and ... | Option Exercise | A | 14.10 | 1,800,000 | 25,380,000 | 1,800,000 | |
Nov 25 2015 | AKTX | Akari Therapeutics ... | Ungar Stuart | Director | Option Exercise | A | 0.19 | 1,088,722 | 208,708 | 1,088,722 | |
Nov 25 2015 | AKTX | Akari Therapeutics ... | Hill James | Director | Option Exercise | A | 0.19 | 1,068,722 | 204,874 | 1,068,722 | |
Nov 25 2015 | AKTX | Akari Therapeutics ... | Shaw Allan | Director | Option Exercise | A | 0.19 | 1,068,722 | 204,874 | 1,068,722 | |
Nov 25 2015 | AKTX | Akari Therapeutics ... | Cohen Mark S | Director | Option Exercise | A | 0.19 | 1,028,722 | 197,206 | 1,028,722 | |
Sep 23 2015 | AKTX | Akari Therapeutics ... | Shaw Allan | Director | Option Exercise | A | 0.32 | 186,278 | 60,000 | 186,278 | |
Sep 23 2015 | AKTX | Akari Therapeutics ... | Shaw Allan | Director | Option Exercise | A | 0.32 | 45,000 | 14,495 | 45,000 | |
Sep 23 2015 | AKTX | Akari Therapeutics ... | Hill James | Director | Option Exercise | A | 0.32 | 231,278 | 74,495 | 231,278 |